These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12699680)

  • 21. Experimental studies on soft contact lenses for controlled ocular delivery of pirfinedone: in vitro and in vivo.
    Yang M; Yang Y; Lei M; Ye C; Zhao C; Xu J; Wu K; Yu M
    Drug Deliv; 2016 Nov; 23(9):3538-3543. PubMed ID: 27331555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and evaluation of a timolol maleate drug-resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo.
    Qin F; Zeng L; Zhu Y; Cao J; Wang X; Liu W
    Drug Dev Ind Pharm; 2016; 42(4):535-45. PubMed ID: 26368660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosslinked soy protein films and their application as ophthalmic drug delivery system.
    González A; Tártara LI; Palma SD; Alvarez Igarzabal CI
    Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():73-9. PubMed ID: 25842110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
    Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
    Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
    Verma P; Gupta RN; Jha AK; Pandey R
    Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop.
    Fedorchak MV; Conner IP; Schuman JS; Cugini A; Little SR
    Sci Rep; 2017 Aug; 7(1):8639. PubMed ID: 28819134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels.
    Wu Y; Yao J; Zhou J; Dahmani FZ
    Int J Nanomedicine; 2013; 8():3587-601. PubMed ID: 24092975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine.
    Lai JY; Hsieh AC
    Biomaterials; 2012 Mar; 33(7):2372-87. PubMed ID: 22182746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of alkyl chain length of monothiol-terminated alkyl carboxylic acid in the synthesis, characterization, and application of gelatin-g-poly(N-isopropylacrylamide) carriers for antiglaucoma drug delivery.
    Luo LJ; Lai JY
    Acta Biomater; 2017 Feb; 49():344-357. PubMed ID: 27890728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combination of guanethidine 3% and adrenaline 0.5% in 1 eyedrop (GA) in glaucoma treatment.
    Hoyng FJ; Dake CL
    Br J Ophthalmol; 1979 Jan; 63(1):56-62. PubMed ID: 570058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of timolol-epinephrine combination on intraocular pressure (author's transl)].
    Arrata M; Massin M
    J Fr Ophtalmol; 1980; 3(5):359-62. PubMed ID: 7400534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermosensitive PHEMA microcarriers: ATRP synthesis, characterization, and usabilities in cell cultures.
    Gümüşderelioğlu M; Çakmak S; Timuçin HÖ; Çakmak AS
    J Biomater Sci Polym Ed; 2013; 24(18):2110-25. PubMed ID: 23930942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Design of Novel Ophthalmic Formulation Containing Drug Nanoparticles and Its Usefulness as Anti-glaucoma Drugs].
    Nagai N
    Yakugaku Zasshi; 2016; 136(10):1385-1390. PubMed ID: 27725388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, characterization and controlled drug release of thermosensitive IPN-PNIPAAm hydrogels.
    Zhang XZ; Wu DQ; Chu CC
    Biomaterials; 2004 Aug; 25(17):3793-805. PubMed ID: 15020155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
    Gupta S; Samanta MK
    Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.
    Chiang B; Kim YC; Doty AC; Grossniklaus HE; Schwendeman SP; Prausnitz MR
    J Control Release; 2016 Apr; 228():48-57. PubMed ID: 26930266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A combination of 1% guanethidine and 0.2% epinephrine in drop form to lower IOP in open-angle glaucoma (author's transl)].
    van Husen H
    Klin Monbl Augenheilkd; 1980 Nov; 177(5):622-7. PubMed ID: 7253518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
    Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
    Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.